The crucial role of predicting brain metastases development in non-small cell lung cancer patients
- 1 September 2018
- journal article
- letter
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 10 (S26) , S3305-S3307
Abstract
The crucial role of predicting brain metastases development in non-small cell lung cancer patientsKeywords
This publication has 14 references indexed in Scilit:
- Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients’ selectionCritical Reviews in Oncology/Hematology, 2018
- Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non–Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 StudyJournal of Clinical Oncology, 2018
- Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenarioCritical Reviews in Oncology/Hematology, 2018
- Brain imaging before primary lung cancer resection: a controversial topicecancermedicalscience, 2017
- BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patientsLung Cancer, 2016
- Non-small cell lung cancer patients with brain metastases treated with first-line platinum-doublet chemotherapy: Analysis from the European FRAME studyLung Cancer, 2015
- Methods for Staging Non-small Cell Lung CancerChest, 2013
- A three-drug induction chemotherapy with gemcitabine, carboplatin, and paclitaxel for stage III non-small cell lung cancerMedical Oncology, 2013
- CXCR4 and CXCL12 immunoreactivities differentiate primary non-small-cell lung cancer with or without brain metastasesCancer Biomarkers, 2012
- Extrathoracic staging is not necessary for non-small-cell lung cancer with clinical stage T1–2 N0The Annals of Thoracic Surgery, 1999